118 related articles for article (PubMed ID: 15637810)
1. Botulinum toxin for treatment of primary chronic headache disorders.
Samson D
Technol Eval Cent Assess Program Exec Summ; 2004 Dec; 19(10):1-3. PubMed ID: 15637810
[No Abstract] [Full Text] [Related]
2. Botulinum toxin for treatment of primary chronic headache disorders.
TEC Bull (Online); 2002 Nov; 19(3):1-5. PubMed ID: 12838976
[No Abstract] [Full Text] [Related]
3. Experience with botulinum toxin type A in medically intractable pediatric chronic daily headache.
Ahmed K; Oas KH; Mack KJ; Garza I
Pediatr Neurol; 2010 Nov; 43(5):316-9. PubMed ID: 20933173
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal shock wave treatment for chronic plantar fasciitis.
Technol Eval Cent Assess Program Exec Summ; 2005 Mar; 19(18):1-4. PubMed ID: 15793942
[No Abstract] [Full Text] [Related]
5. Botulinum toxin for chronic migraine.
Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
[No Abstract] [Full Text] [Related]
6. Botulinum toxin in headache treatment: the end of the road?
Mauskop A
Cephalalgia; 2007 May; 27(5):468. PubMed ID: 17448184
[No Abstract] [Full Text] [Related]
7. OnabotulinumtoxinA for the treatment of chronic migraine.
Rothrock JF
Headache; 2011 Apr; 51(4):659-60. PubMed ID: 21457253
[No Abstract] [Full Text] [Related]
8. The use of botulinum toxin in the treatment of headaches.
Mauskop A
Curr Pain Headache Rep; 2002 Aug; 6(4):320-3. PubMed ID: 12095468
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin: does the black box warning justify change in practice?
Narayanan UG
Dev Med Child Neurol; 2011 Feb; 53(2):101-2. PubMed ID: 21244406
[No Abstract] [Full Text] [Related]
10. Pancreas retransplantation.
Tecnologica MAP Suppl; 2001 Dec; ():33-7. PubMed ID: 11933940
[No Abstract] [Full Text] [Related]
11. Botulinum toxin in headache treatment: the end of the road?
Evers S; Olesen J
Cephalalgia; 2006 Jul; 26(7):769-71. PubMed ID: 16776690
[No Abstract] [Full Text] [Related]
12. Botox-A for suppression of chronic migraine: commonly asked questions.
Rothrock JF
Headache; 2012 Apr; 52(4):716-7. PubMed ID: 22486743
[No Abstract] [Full Text] [Related]
13. Use of implantable cardioverter-defibrillators for prevention of sudden death in patients at high risk for ventricular arrhythmia.
Technol Eval Cent Assess Program Exec Summ; 2005 Mar; 19(19):1-6. PubMed ID: 15793938
[No Abstract] [Full Text] [Related]
14. Status on the use of botulinum toxin for headache disorders.
Evers S
Curr Opin Neurol; 2006 Jun; 19(3):310-5. PubMed ID: 16702841
[TBL] [Abstract][Full Text] [Related]
15. Transcranial magnetic stimulation for the treatment of schizophrenia.
Technol Eval Cent Assess Program Exec Summ; 2011 Nov; 26(6):1-3. PubMed ID: 22724161
[No Abstract] [Full Text] [Related]
16. Special report: maintenance therapy in advanced non-small-cell lung cancer.
Technol Eval Cent Assess Program Exec Summ; 2011 Jul; 26(4):1-3. PubMed ID: 22022747
[No Abstract] [Full Text] [Related]
17. Metal-on-metal total hip resurfacing.
BlueCross BlueShield Association
Technol Eval Cent Assess Program Exec Summ; 2007 Jun; 22(3):1-4. PubMed ID: 17621693
[No Abstract] [Full Text] [Related]
18. Artificial lumbar disc replacement.
BlueCross BlueShield Association
Technol Eval Cent Assess Program Exec Summ; 2007 Jun; 22(2):1-3. PubMed ID: 17621692
[No Abstract] [Full Text] [Related]
19. Cardiac resynchronization therapy for mild heart failure.
Technol Eval Cent Assess Program Exec Summ; 2011 Jul; 26(1):1-5. PubMed ID: 22022744
[No Abstract] [Full Text] [Related]
20. Radiofrequency catheter ablation of the pulmonary veins for treatment of atrial fibrillation.
Technol Eval Cent Assess Program Exec Summ; 2009 Apr; 23(11):1-5. PubMed ID: 19824217
[No Abstract] [Full Text] [Related]
[Next] [New Search]
